YU45350B - Process for obtaining dimethylformamudic solvent 3-propenil cephalosporine - Google Patents

Process for obtaining dimethylformamudic solvent 3-propenil cephalosporine

Info

Publication number
YU45350B
YU45350B YU1310/86A YU131086A YU45350B YU 45350 B YU45350 B YU 45350B YU 1310/86 A YU1310/86 A YU 1310/86A YU 131086 A YU131086 A YU 131086A YU 45350 B YU45350 B YU 45350B
Authority
YU
Yugoslavia
Prior art keywords
dimethylformamudic
propenil
cephalosporine
solvent
obtaining
Prior art date
Application number
YU1310/86A
Other languages
English (en)
Other versions
YU131086A (en
Inventor
Jr L B Crast
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of YU131086A publication Critical patent/YU131086A/xx
Publication of YU45350B publication Critical patent/YU45350B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/187-Aminocephalosporanic or substituted 7-aminocephalosporanic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/227-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Peptides Or Proteins (AREA)
YU1310/86A 1985-07-29 1986-07-22 Process for obtaining dimethylformamudic solvent 3-propenil cephalosporine YU45350B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/759,805 US4694079A (en) 1985-07-29 1985-07-29 3-propenyl cephalosporin solvates

Publications (2)

Publication Number Publication Date
YU131086A YU131086A (en) 1987-10-31
YU45350B true YU45350B (en) 1992-05-28

Family

ID=25057020

Family Applications (1)

Application Number Title Priority Date Filing Date
YU1310/86A YU45350B (en) 1985-07-29 1986-07-22 Process for obtaining dimethylformamudic solvent 3-propenil cephalosporine

Country Status (17)

Country Link
US (1) US4694079A (es)
KR (1) KR930004014B1 (es)
CN (1) CN1015263B (es)
AR (1) AR243530A1 (es)
AT (1) AT389876B (es)
CA (1) CA1262345A (es)
CS (1) CS258143B2 (es)
DD (1) DD248594A5 (es)
EG (1) EG18112A (es)
ES (1) ES2001338A6 (es)
FI (1) FI84269C (es)
GR (1) GR861988B (es)
HU (1) HU195224B (es)
NO (1) NO167461C (es)
PT (1) PT83074B (es)
SU (1) SU1414317A3 (es)
YU (1) YU45350B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5128336A (en) * 1988-03-23 1992-07-07 Eli Lilly And Company 3-(substituted)-1-carba(dethia)-3-cephems
AT399876B (de) * 1992-02-05 1995-08-25 Biochemie Gmbh Verfahren zur abreicherung von 7-amino-3-((e)-1- propen-1-yl)-3-cephem-4-carbonsäure
KR950700311A (ko) * 1992-02-05 1995-01-16 게오르게스 그렐리니, 한스 루돌프하우스 3-세펨-4-카복실산 유도체의 정제방법(Process for the purification of a 3-cephem-4-carboxylic acid derivatives)
PT102061B (pt) * 1997-10-08 2000-06-30 J K Ind Ltd Processo de preparacao de um antibiotico cefalosporina geralmente activo-cefixime
ATE335747T1 (de) * 1999-09-30 2006-09-15 Otsuka Kagaku Kk Kristallines 3-cephem derivat
KR100408430B1 (ko) * 2001-04-18 2003-12-06 한미약품 주식회사 3-(z)-프로페닐 세펨 화합물의 선택적인 제조 방법
US6903211B2 (en) * 2002-10-30 2005-06-07 Orchid Chemicals & Pharmaceuticals Limited Process for the preparation of 3-propenyl cephalosporin DMF solvate
US7230097B2 (en) * 2003-03-10 2007-06-12 Lupin Ltd. Process for preparation of 7-[α-Amino (4-hydroxyphenyl) acetamido]-3-substituted-3-cephem-4-carboxylic acid
EP1638520A2 (en) * 2003-06-19 2006-03-29 Ranbaxy Laboratories Limited Solvates of cefprozil
KR100576336B1 (ko) * 2003-10-30 2006-05-03 씨제이 주식회사 세팔로스포린 유도체의 제조방법
US20070072945A1 (en) * 2004-03-31 2007-03-29 Pohoreski Anton Sulphur-containing oils for controlling plant pathogens and stimulating nutrient uptake
PL1809638T3 (pl) * 2004-11-01 2010-07-30 Hetero Drugs Ltd Nowy sposób wytwarzania związków pośrednich w syntezie cefprozilu
CN101058584B (zh) * 2007-05-23 2010-05-26 上海骏捷生化科技有限公司 一种制备头孢丙烯母核7-氨基-3-丙烯基头孢烷酸的方法
CN103524533B (zh) * 2013-10-10 2016-01-27 珠海金鸿药业股份有限公司 一种头孢丙烯化合物、其分散片、干混悬剂及制备方法
CN108017658B (zh) * 2017-12-26 2020-06-16 山东裕欣药业有限公司 一种头孢丙烯的合成方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3985741A (en) * 1972-09-15 1976-10-12 Bristol-Myers Company Production of p-hydroxycephalexin
DE3381408D1 (de) * 1982-12-27 1990-05-10 Lilly Co Eli Zwischenverbindungen fuer die herstellung von ceftazidin und verfahren zu ihrer herstellung.
US4520022A (en) * 1983-01-28 1985-05-28 Bristol-Myers Company Substituted vinyl cephalosporins

Also Published As

Publication number Publication date
AR243530A1 (es) 1993-08-31
CS258143B2 (en) 1988-07-15
EG18112A (en) 1992-08-30
FI84269B (fi) 1991-07-31
SU1414317A3 (ru) 1988-07-30
CN1015263B (zh) 1992-01-01
CN86105568A (zh) 1987-04-01
HU195224B (en) 1988-04-28
DD248594A5 (de) 1987-08-12
CA1262345A (en) 1989-10-17
FI863066A (fi) 1987-01-30
YU131086A (en) 1987-10-31
ES2001338A6 (es) 1988-05-16
CS561386A2 (en) 1987-09-17
GR861988B (en) 1986-12-22
KR930004014B1 (ko) 1993-05-19
NO862970D0 (no) 1986-07-24
NO167461B (no) 1991-07-29
FI863066A0 (fi) 1986-07-25
AT389876B (de) 1990-02-12
PT83074A (en) 1986-08-01
NO167461C (no) 1991-11-06
HUT41799A (en) 1987-05-28
US4694079A (en) 1987-09-15
NO862970L (no) 1987-01-30
FI84269C (fi) 1991-11-11
PT83074B (pt) 1989-06-30
KR870001216A (ko) 1987-03-12
ATA202886A (de) 1989-07-15

Similar Documents

Publication Publication Date Title
YU134186A (en) Process for obtaining new antihypertenzic compounds
YU154986A (en) Process for obtaining bis-phosphitic compounds
YU130387A (en) Process for drying
YU116787A (en) Process for obtaining imidazochynolinic derivatives
YU183586A (en) Process for obtaining chynoline derivatives
PT82062A (en) Process for preparing pyridinylimidazolidinone compounds
YU99386A (en) Process for obtaining new thienopyridones
YU45350B (en) Process for obtaining dimethylformamudic solvent 3-propenil cephalosporine
EP0199997A3 (en) Process for preparing diaryl-pentaerythritol
YU202686A (en) Process for obtaining hynolone
YU210187A (en) Process for obtaining imidazolylalkylguanidinic derivatives
GR861004B (en) Process for preparing fluorized benzyltriazol compounds
PT83293B (en) Process for preparing dihidropyridine-2-hydroxyamines useful asmedicaments
PT83154A (en) Process for preparing quinolizinesulphonamides
HUT42766A (en) Process for preparing n-sulfamyl-3-(2-guanidino-thiazolyl-4-methyl-thio)-propionamidine
ZA863454B (en) Process for preparing benzothiazolesulphenamides
YU100886A (en) Process for obtaining 2-bromine-alpha-ergocriptine
HUT40795A (en) Process for preparing fluoro-alkane compounds
PT82643A (en) Process for preparing substituted hexanydro arylquinolizines
PT83959B (en) Process for preparing novel substituted arylfluorazolylalkanols
HUT42438A (en) Process for preparing novel 4-alkoxy-2-oxo-pyrrolidin-1-yl-acetic acid-alkylesters
HUT43039A (en) Process for preparing 4-hydroxy-2-oxo-pyrrolidin-1-yl-acetamide
HUT42769A (en) Process for preparing pyridazodiazepines
GB2171096B (en) Process for preparing pyrone-3-carboxamide compounds
ZA858865B (en) Process for preparing mixtures